WO2018105755A1 - Cosmetics containing nanoparticles having encapsulated therein whitening-improving active ingredient, and method for producing said cosmetics - Google Patents
Cosmetics containing nanoparticles having encapsulated therein whitening-improving active ingredient, and method for producing said cosmetics Download PDFInfo
- Publication number
- WO2018105755A1 WO2018105755A1 PCT/KR2016/014163 KR2016014163W WO2018105755A1 WO 2018105755 A1 WO2018105755 A1 WO 2018105755A1 KR 2016014163 W KR2016014163 W KR 2016014163W WO 2018105755 A1 WO2018105755 A1 WO 2018105755A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- whitening
- weight
- whitening improvement
- nanoparticles
- glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to a cosmetic for improving skin whitening, and more particularly, to a field of cosmetics including nanoparticles that have increased solubility in water by micellizing a hydrophobic whitening improving substance.
- Glabridine a substance that is effective in whitening and improvement in the present invention, is a fat-soluble antioxidant obtained from licorice, and shows excellent efficacy in inhibiting oxidation, inflammation, and aging of low-density lipoproteins that are harmful to the human body. It has an excellent effect on the anti-tyrosinase activity compared to other whitening ingredients known to this effect, there is an increasing number of examples of producing a functional cosmetic with a whitening effect using it.
- glabridine or whitening improvers extracted from licorice are hydrophobic and have low solubility in water, making them difficult to apply to functional cosmetics having a whitening effect.
- Patent Document 1 biocompatible biodegradable polymer PEG-PCL-PEG triblock copolymer
- Patent Document 2 biocompatible biodegradable polymer PEG-PCL-PEG triblock copolymer
- Patent Document 2 biocompatible biodegradable polymer PEG-PCL-PEG triblock copolymer
- Efforts have been made to further include phospholipids (Patent Document 2), but the long-term stability of the biodegradable polymer PEG-PCL-PEG triblock copolymer used is poor and the composition prepared therefrom contains solvents and additives, The disadvantage is that it takes a long time to solubilize.
- Patent Document 3 forms a complex of Gemini-type surfactant, higher alcohol, co-emulsifier, ceramide, cholesterol, etc., having two hydrophilic groups and two hydrophobic groups in one molecule, which are completely different from those of the conventional surfactant.
- the present invention discloses a cosmetic composition in which oil-soluble licorice extract is stabilized in the interfacial multiliquid crystal, but the interfacial multiliquid crystal has a problem of poor skin penetration effect due to a large problem of particle size of about 1.0 to 3.0 ⁇ m in the shape of four petals. .
- Patent Document 4 discloses nanoparticles in which at least one hydrophobic active ingredient is stabilized using a biodegradable polymer, but does not contain an antioxidant, so that the hydrophobic active ingredient may be oxidized and discolored over time. This is large, there is a problem in that the stability of the particles and the efficiency of skin absorption enhancement of the active ingredient is inferior.
- the present inventors can prepare a whitening improvement active material such as licorice extract glabridine without a solvent or other additives in a simple way, and increase the solubility in water, even after a long time, whitening improvement nanoparticles excellent skin penetration While making efforts to make the composition, the whitening improvement nanoparticle composition of the present invention was confirmed to maintain a stable particle shape even after a long time, solubility and easy skin permeation completed the present invention.
- an object of the present invention is to provide a cosmetic containing nanoparticles are sealed whitening improvement material excellent in long-term stability and skin penetration.
- the present invention is to realize the desired object as described above,
- whitening improvement active substance 1 part by weight of whitening improvement active substance; 1 to 30 parts by weight of a glycol solvent; 1 to 30 parts by weight of a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)]; And a skin permeation promoter 0.5 to 30 parts by weight;
- whitening improvement active substance 1 part by weight of whitening improvement active substance; 1 to 30 parts by weight of a glycol solvent; And stirring the mixture to which 1 to 30 parts by weight of a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)] is added (step 1); And a skin permeation promoter 0.5 to 30 parts by weight to the mixture; adding and dispersing (step 2).
- PEO polyethylene oxide
- PPO polypropylene oxide
- PEO polyethylene oxide
- Cosmetics according to the present invention presented as described above can obtain the effect of improving the skin permeability of the whitening improvement active material through the nanoparticles containing the whitening improvement active material excellent in long-term stability and skin penetration.
- FIG. 1 is a view showing a whitening improvement nanoparticles of cosmetics containing a nanoparticles containing the whitening improvement active material according to the present invention.
- Figure 2 is a photograph of diluting the whitening improvement nanoparticles of Example 1 in water.
- Figure 3 is a photograph of diluting the whitening improvement nanoparticles of Example 2 in water.
- Figure 4 is a photograph of diluting the whitening improvement nanoparticles of Example 3 in water.
- Example 5 is a photograph of diluting the whitening improvement nanoparticles of Example 4 in water.
- Example 6 is a photograph of the discolored whitening improvement nanoparticles of Example 4 after one month.
- Example 7 is a photograph of the discolored whitening improvement nanoparticles of Example 5 after one month.
- Example 8 is a graph showing the size of the gloridine particle of Example 2 over time.
- Example 9 is a graph showing the particle size distribution of Example 1 measured.
- Example 10 is a graph showing the particle size distribution of Example 2 measured.
- Example 11 is a graph showing the particle size distribution of Example 3 measured.
- Example 12 is a graph showing the particle size distribution of Example 4 measured.
- Example 13 is a graph showing the particle size distribution of Example 5 measured.
- the present invention is 1 part by weight of whitening improvement active material
- a cosmetic comprising a nanoparticles containing a whitening improvement active material, including; 0.5 to 30 parts by weight of a skin permeation accelerator.
- the nanoparticles preferably have a particle size of 20 to 150 nm.
- the whitening improvement active material is glabridin, Boswellin CG, Alma extract, Alpha lipoate, Sabi white, Sim white 377), rucinol, curcuminoids and the like can be used, with the use of glabridine or shim white.
- the curcuminoid is preferably curcumin.
- glycol solubilizers serve to dissolve the whitening improvement active material to micellize.
- the glycol dissolving agent may be ethylene glycol, propylene glycol, tetraethylene glycol, polyethylene glycol, polypropylene glycol, polybutylene glycol, and the like, preferably a compound represented by the following formula (1).
- R 1 is hydrogen or methyl
- R 2 is hydrogen or an ester group
- a is an integer of 1 to 200.
- the glycol dissolving agent may be used 1 to 30 parts by weight, preferably 5 to 20 parts by weight, most preferably 10 parts by weight based on 1 part by weight of the whitening improvement active substance. If the glycol-based solubilizer is contained in an amount of less than 1 part by weight based on 1 part by weight of the whitening-improving active substance, the dispersion of the whitening-improving active substance is incomplete, which makes it difficult to release the whitening-improving active substance in future use. If it exceeds 30 parts by weight with respect to 1 part by weight of the effective active material, there is a problem that the stability of the whitening improvement active material is insufficient and the reagent is wasted.
- glycofurol, polysorbate, cremophore, solutol HS (Solutol HS 15) and the like may be further mixed and used.
- the triblock copolymers in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)] play a role of micelle formation and have poloxamer 184, poloxamer 185, poloxamer 188, and polox.
- Sammer 124, Poloxamer 237, Poloxamer 338, Poloxamer 407 and the like can be used.
- triblock copolymers are compounds represented by the following formula (2).
- b, c and d are independently integers from 1 to 200.
- the skin permeation promoter is preferably contained in 0.5 to 30 parts by weight based on 1 part by weight of the whitening improvement active substance. If the skin permeation accelerator is contained in an amount of less than 0.5 parts by weight based on 1 part by weight of the whitening improvement active substance, there is a problem that skin permeability is not secured, and 30 parts by weight based on 1 part by weight of the whitening improvement active substance. If it exceeds, there is a problem in that excess amount of the skin permeation accelerator required for skin permeation is contained and the reagent is wasted.
- the antioxidant is contained in an amount of less than 0.1 part by weight based on 1 part by weight of the whitening improvement active material, there is a problem that does not prevent the oxidation of the whitening improvement active material. In this case, there is a problem that the reagent is wasted because an excess amount of the antioxidant is required to prevent oxidation of the whitening improvement active substance.
- the present invention is a step of adding and stirring a glycol dissolving agent and a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)] to the whitening improvement active material (step 1) ;
- the manufacturing method according to the present invention can produce a cosmetic including nanoparticles having a particle size of 20 to 150 nm in which the whitening improvement active material is encapsulated.
- the nanoparticles produced by the manufacturing method improve the solubility of the cosmetic containing the nanoparticles and excellent long-term stability, it is useful as a manufacturing method that can improve the applicability of the whitening improvement active material as a whitening improvement cosmetics Can be used.
- step by step of a cosmetic manufacturing method comprising a nanoparticle encapsulated whitening improvement active material according to the present invention.
- step 1 is a glycol dissolving agent and a [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO) )] Is a step of adding and stirring the triblock copolymers in the form.
- PEO polyethylene oxide
- PPO polypropylene oxide
- PEO polyethylene oxide
- the stirring temperature may be 20 to 100 °C, 40 to 80 °C is preferred.
- step 2 is a step of dispersing by adding a skin permeation promoter.
- the step of performing the step 1 before the step 2 may be further performed by adding an antioxidant.
- Glavdine was prepared by purchasing a product developed by Intubio as a licorice-derived oil-soluble ingredient.
- Sim white 377 (Phenylethyl Resorcinol) was prepared and purchased from Symrise, Germany.
- Polyethylene glycol (PEG400) 100 mg was added to 10 mg of shim white, followed by addition of poloxamer 188 (F-68, 100 mg), a triblock copolymer, and melted at 60 ° C. to prepare a cosmetic containing liquid shim white nanoparticles. (FIG. 4).
- PEG400 Polyethylene glycol (PEG400) (100 mg) and ⁇ -tocopherol (5 mg), antioxidants, were added to Shim White, and poloxamer 188 (F-68, 100 mg), a triblock copolymer, was melted at 60 ° C and then dissolved in liquid nano. Particles were prepared, and 100 mg of skin permeation accelerator (Brij 58) was added to the prepared whitening nanoparticle composition to prepare a cosmetic including whitening nanoparticles that are stable to oxidation reaction and promote skin permeation.
- Brij 58 skin permeation accelerator
- the whitening improvement nanoparticles of Examples 1 to 5 prepared above were observed with the naked eye over time after preparation, and the results are shown in Table 1, and the result was visually observed after one month to observe the discoloration over time. 6 and 7 show the results, and the particle size of the gloridine of Example 2 over time was measured and shown in FIG. 8.
- Example 1 Example 2
- Example 3 Example 4
- Example 5 Sedimentation O X O X X
- Table 1 is a table showing the precipitation of Examples 1 to 5.
- Example 6 is a photograph of the discolored whitening improvement nanoparticles of Example 4 after one month.
- Example 7 is a photograph of the discolored whitening improvement nanoparticles of Example 5 after one month.
- FIG. 8 is a graph showing the particle size of the glabridine over time according to the present invention.
- Example 4 after one month, the whitening improvement compound was oxidized and discolored. However, in Example 5, discoloration does not occur even after one month, and thus whitening improvement nanoparticles are stable to the oxidation reaction. .
- the glabridine of the whitening improved nanoparticles according to the present invention can be seen that the long-term stability is excellent as it maintains the particle size even after 6 months.
- the whitening improvement nanoparticles according to the present invention have excellent solubility including skin permeation accelerator, and further include an antioxidant to prevent oxidation of the whitening improvement substance, thereby improving long-term stability, and its particle size even after a long time Since it can be maintained, it can be usefully used as a cosmetic for improving whitening by containing it as an active ingredient.
- Example 1 to 5 The particle size of Examples 1 to 5 was measured to evaluate whether the cosmetic including the whitening-improving nanoparticles according to the present invention has a size suitable for skin permeation.
- Example One 2 3 4 5 Particle size (nm) 240.5 38.9 190.4 30.4 43.2
- a cosmetic including the whitening-improving nanoparticles of the present invention can easily obtain the effect of permeating the skin.
- Table 3 shows that arbutin exhibits a tyrosinase inhibitory effect of 50 to 70% even when tested with a relatively high concentration of solution, whereas glabridine and seam white nanoparticles, which are easy to penetrate the skin even with a relatively low concentration of solution, It was found that the tyrosinase was suppressed by an effect of 80% or more, which shows that the melanogenesis was excellently suppressed.
- the whitening improvement active substance of the present invention is excellent in whitening improvement by inhibiting melanin formation, and cosmetics containing the whitening improvement nanoparticles of the present invention containing the same as an active ingredient can obtain the effect of whitening improvement.
- the cosmetics containing the whitening improvement nanoparticles according to the present invention has a small particle size (20 to 150nm) is excellent in solubility and skin permeability, effectively oxidizing the whitening improvement compound Because it prevents the long-term stability is excellent, it can be usefully used as a whitening improvement cosmetics containing it as an active ingredient.
- the cosmetic containing the nanoparticles containing the whitening improvement active material of the above configuration can be configured to be mixed in the cosmetic composition according to a known technique, each composition ratio can be appropriately configured according to the judgment of those skilled in the art.
- the cosmetics according to the present invention can be used as an active ingredient of cosmetics that can be classified into a kind such as skin, toner, essence, emulsion, lotion, cream, face mist, cleansing or face pack emulsion. That is, the kind of cosmetics can be divided according to the dosage form as an active ingredient according to the present invention and may further comprise a variety of carrier components for forming each formulation.
- the cosmetic according to the present invention is an active ingredient
- the formulation of the cosmetic to be prepared is a paste, cream or gel
- the carrier component is animal fiber, plant fiber, wax, paraffin, starch, trakant, cellulose derivative.
- Polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used.
- the carrier component is aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, already Dazolinium derivatives, methyltaurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters The above can be used.
- the carrier of this kind may be mixed with cosmetics according to the present invention (which serves as an active ingredient of the cosmetics to be manufactured) in various composition ratios, and the preferred composition ratios thereof are known according to the use of the cosmetics produced.
- the technique can be applied as appropriate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 피부 미백개선을 위한 화장품에 관한 것으로서, 보다 상세하면 소수성인 미백개선 유효물질을 마이셀화하여 물에 대한 용해도를 높인 나노입자를 포함하는 화장품에 관한 분야이다.The present invention relates to a cosmetic for improving skin whitening, and more particularly, to a field of cosmetics including nanoparticles that have increased solubility in water by micellizing a hydrophobic whitening improving substance.
본 발명에서 사용되는 미백개선에 효능이 있는 물질인 글라브리딘은 감초로부터 얻어지는 지용성 항산화제로서 인체에 해로운 저밀도 지질단백질의 산화억제, 염증억제, 노화 방지등에 우수한 효능을 보일 뿐만 아니라, 멜라닌 합성에 대한 작용으로 현재까지 알려진 다른 미백원료들에 비해 항티로시나아제 활성에 탁월한 효과를 지니고 있어, 이를 이용하여 미백효과가 있는 기능성 화장품을 제조하는 예가 증가하고 있다. 그러나 감초로부터 추출된 글라브리딘 또는 미백개선제들은 소수성으로서 물에 대한 낮은 용해도를 가지고 있기 때문에 미백효과가 있는 기능성 화장품에 응용하기에는 어려운 점이 있다.Glabridine, a substance that is effective in whitening and improvement in the present invention, is a fat-soluble antioxidant obtained from licorice, and shows excellent efficacy in inhibiting oxidation, inflammation, and aging of low-density lipoproteins that are harmful to the human body. It has an excellent effect on the anti-tyrosinase activity compared to other whitening ingredients known to this effect, there is an increasing number of examples of producing a functional cosmetic with a whitening effect using it. However, glabridine or whitening improvers extracted from licorice are hydrophobic and have low solubility in water, making them difficult to apply to functional cosmetics having a whitening effect.
이런 문제들을 해결하기 위해 글라브리딘 및 여러 미백개선물질을 생체친화형 생분해성 고분자인 PEG-PCL-PEG 트리블록공중합체를 이용하거나(특허문헌 1), PEG-PCL-PEG 트리블록공중합체에 인지질을 더 포함하여 가용화하려는 노력이 있었으나(특허문헌 2), 사용되는 생분해성 고분자 PEG-PCL-PEG 트리블록 공중합체의 장기안정성이 좋지 않고 또한 이로부터 제조되는 조성물은 용매와 첨가제가 들어갈 뿐만 아니라 가용화하기까지 시간이 오래 걸린다는 단점이 있다.In order to solve these problems, glabridine and various whitening improvers are used in the biocompatible biodegradable polymer PEG-PCL-PEG triblock copolymer (Patent Document 1) or PEG-PCL-PEG triblock copolymer. Efforts have been made to further include phospholipids (Patent Document 2), but the long-term stability of the biodegradable polymer PEG-PCL-PEG triblock copolymer used is poor and the composition prepared therefrom contains solvents and additives, The disadvantage is that it takes a long time to solubilize.
또한, 특허문헌 3에는 종래의 계면활성제의 구조와 완전히 다른 두 개의 친수기와 두 개의 소수기를 한 분자에 동시에 갖는 제미니(Gemini)형 계면활성제, 고급알코올, 보조유화제, 세라마이드, 콜레스테롤 등을 복합체로 형성시킨 계면다중액정 내에 유용성 감초추출물을 안정화시킨 화장료 조성물을 개시하고 있으나, 상기 계면다중액정은 4개의 꽃잎모양으로 입자 크기가 약 1.0 내지 3.0㎛로 큰 문제가 있어 피부침투효과가 좋지 못한 문제가 있다.In addition,
나아가, 특허문헌 4에는 생분해성 고분자를 이용하여 1종 이상의 소수성 활성성분을 안정화한 나노입자에 대하여 개시하고 있으나, 항산화제를 함유하고 있지 않아 소수성 활성성분이 시간이 경과함에 따라 산화되어 변색될 가능성이 크며, 입자의 안정성과 상기 활성성분의 피부흡수증진 등의 효율이 떨어지는 문제가 있다.Furthermore,
이에, 본 발명자들은 감초 추출물인 글라브리딘 등의 미백개선 유효물질을 간단한 방법으로 용매나 별다른 첨가제 없이 제조할 수 있고 물에 대한 용해성을 증가시키면서 장시간 경과 후에도 안정적이고 피부투과가 우수한 미백개선 나노입자 조성물을 만들기 위해 노력하던 중, 본 발명의 미백개선 나노입자 조성물이 장시간 경과 후에도 안정하게 입자형태를 유지하며 가용성이 좋고 피부투과가 용이함을 확인하여 본 발명을 완성하였다.Thus, the present inventors can prepare a whitening improvement active material such as licorice extract glabridine without a solvent or other additives in a simple way, and increase the solubility in water, even after a long time, whitening improvement nanoparticles excellent skin penetration While making efforts to make the composition, the whitening improvement nanoparticle composition of the present invention was confirmed to maintain a stable particle shape even after a long time, solubility and easy skin permeation completed the present invention.
본 발명은 화장품의 종래기술에 따른 문제점들을 개선하고자 안출된 기술로서, 장기안정성 및 피부투과가 우수한 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품을 제공하는 것을 목적으로 한다.The present invention has been made in order to improve the problems according to the prior art of cosmetics, an object of the present invention is to provide a cosmetic containing nanoparticles are sealed whitening improvement material excellent in long-term stability and skin penetration.
본 발명은 상기와 같은 소기의 목적을 실현하고자,The present invention is to realize the desired object as described above,
미백개선 유효물질 1 중량부; 글리콜류 용해제 1 내지 30 중량부; [폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)] 형태의 트리블록 공중합체류 1 내지 30 중량부; 및 피부투과촉진제 0.5 내지 30 중량부;를 포함하는 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품을 제시하고,1 part by weight of whitening improvement active substance; 1 to 30 parts by weight of a glycol solvent; 1 to 30 parts by weight of a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)]; And a skin permeation promoter 0.5 to 30 parts by weight;
미백개선 유효물질 1 중량부; 글리콜류 용해제 1 내지 30 중량부; 및 [폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)] 형태의 트리블록 공중합체류 1 내지 30 중량부를 첨가한 혼합물을 교반하는 단계(단계 1); 및 상기 혼합물에 피부투과촉진제 0.5 내지 30 중량부;를 첨가하여 분산시키는 단계(단계 2);를 포함하는 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품 제조방법을 제시한다.1 part by weight of whitening improvement active substance; 1 to 30 parts by weight of a glycol solvent; And stirring the mixture to which 1 to 30 parts by weight of a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)] is added (step 1); And a skin permeation promoter 0.5 to 30 parts by weight to the mixture; adding and dispersing (step 2).
상기와 같이 제시된 본 발명에 의한 화장품은 장기안정성 및 피부투과가 우수한 미백개선 유효물질이 봉입된 나노입자를 통하여, 미백개선 유효물질의 피부투과를 향상시킬 수 있는 효과를 얻을 수 있다.Cosmetics according to the present invention presented as described above can obtain the effect of improving the skin permeability of the whitening improvement active material through the nanoparticles containing the whitening improvement active material excellent in long-term stability and skin penetration.
도 1은 본 발명에 따른 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품의 미백개선 나노입자를 나타내는 그림이다.1 is a view showing a whitening improvement nanoparticles of cosmetics containing a nanoparticles containing the whitening improvement active material according to the present invention.
도 2는 실시예 1의 미백개선 나노입자를 물에 희석한 사진이다.Figure 2 is a photograph of diluting the whitening improvement nanoparticles of Example 1 in water.
도 3은 실시예 2의 미백개선 나노입자를 물에 희석한 사진이다.Figure 3 is a photograph of diluting the whitening improvement nanoparticles of Example 2 in water.
도 4는 실시예 3의 미백개선 나노입자를 물에 희석한 사진이다.Figure 4 is a photograph of diluting the whitening improvement nanoparticles of Example 3 in water.
도 5는 실시예 4의 미백개선 나노입자를 물에 희석한 사진이다.5 is a photograph of diluting the whitening improvement nanoparticles of Example 4 in water.
도 6은 1개월 후, 실시예 4의 변색 된 미백개선 나노입자의 사진이다.6 is a photograph of the discolored whitening improvement nanoparticles of Example 4 after one month.
도 7은 1개월 후, 실시예 5의 변색 된 미백개선 나노입자의 사진이다.7 is a photograph of the discolored whitening improvement nanoparticles of Example 5 after one month.
도 8은 실시예 2의 글라브리딘 입자크기를 시간 경과에 따라 나타낸 그래프다.8 is a graph showing the size of the gloridine particle of Example 2 over time.
도 9는 측정된 실시예 1의 입자크기 분포를 나타낸 그래프이다.9 is a graph showing the particle size distribution of Example 1 measured.
도 10는 측정된 실시예 2의 입자크기 분포를 나타낸 그래프이다.10 is a graph showing the particle size distribution of Example 2 measured.
도 11는 측정된 실시예 3의 입자크기 분포를 나타낸 그래프이다.11 is a graph showing the particle size distribution of Example 3 measured.
도 12는 측정된 실시예 4의 입자크기 분포를 나타낸 그래프이다.12 is a graph showing the particle size distribution of Example 4 measured.
도 13은 측정된 실시예 5의 입자크기 분포를 나타낸 그래프이다.13 is a graph showing the particle size distribution of Example 5 measured.
도 14는 실험예 2의 실험사진이다.14 is an experimental photograph of Experimental Example 2.
이하, 본 발명을 첨부한 도면을 참고하여 구체적으로 설명하면 다음과 같다.Hereinafter, described in detail with reference to the accompanying drawings of the present invention.
[미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품]Cosmetics Containing Nanoparticles Encapsulated with Whitening Improvement
본 발명은 미백개선 유효물질 1 중량부;The present invention is 1 part by weight of whitening improvement active material;
글리콜류 용해제 1 내지 30 중량부;1 to 30 parts by weight of a glycol solvent;
[폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)] 형태의 트리블록 공중합체류 1 내지 30 중량부; 및1 to 30 parts by weight of a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)]; And
피부투과촉진제 0.5 내지 30 중량부;를 포함하는, 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품을 제공한다. 이때, 상기 나노입자는 20 내지 150 nm 입자크기를 갖는 것이 바람직하다.It provides a cosmetic comprising a nanoparticles containing a whitening improvement active material, including; 0.5 to 30 parts by weight of a skin permeation accelerator. At this time, the nanoparticles preferably have a particle size of 20 to 150 nm.
여기서, 상기 미백개선 유효물질은 글라브리딘(glabridin), 보스웰린 씨지(Boswellin CG), 알마 익스트랙트(Alma extract), 알파 리포에이트(Alpha lipoate), 사비 화이트(Sabi white), 심 화이트(Symwhite 377), 루시놀, 커큐미노이드 등을 사용할 수 있으며, 글라브리딘 또는 심 화이트를 사용하는 것이 바람직하다. 이때, 상기 커큐미노이드는 바람직하게 커큐민이다.Here, the whitening improvement active material is glabridin, Boswellin CG, Alma extract, Alpha lipoate, Sabi white, Sim white 377), rucinol, curcuminoids and the like can be used, with the use of glabridine or shim white. At this time, the curcuminoid is preferably curcumin.
또한, 상기 글리콜류 용해제는 미백개선 유효물질를 마이셀화시키기 위하여 용해시키는 역할을 수행한다.In addition, the glycol solubilizers serve to dissolve the whitening improvement active material to micellize.
이때, 상기 글리콜류 용해제는 에틸렌글리콜, 프로필렌글리콜, 테트라에틸렌글리콜, 폴리에틸렌글리콜, 폴리프로필렌글리콜, 폴리부틸렌글리콜 등을 사용할 수 있고, 바람직하게 하기 화학식 1로 표시되는 화합물이다.In this case, the glycol dissolving agent may be ethylene glycol, propylene glycol, tetraethylene glycol, polyethylene glycol, polypropylene glycol, polybutylene glycol, and the like, preferably a compound represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에서,In Chemical Formula 1,
R1은 수소 또는 메틸이고;R 1 is hydrogen or methyl;
R2는 수소 또는 에스테르기이고; 및R 2 is hydrogen or an ester group; And
a는 1 내지 200의 정수이다.a is an integer of 1 to 200.
이때, 상기 글리콜류 용해제는 미백개선 유효물질 1 중량부에 대하여 1 내지 30 중량부를 사용할 수 있고, 5 내지 20 중량부를 사용하는 것이 바람직하고, 10 중량부를 사용하는 것이 가장 바람직하다. 만약, 상기 글리콜류 용해제가 미백개선 유효물질 1 중량부에 대하여 1 중량부 미만으로 함유되는 경우에는 미백개선 유효물질의 분산이 불완전해 추후 사용시 미백개선 유효물질의 방출이 어려워지는 문제가 있고, 미백개선 유효물질 1 중량부에 대하여 30 중량부를 초과하는 경우에는 미백개선 유효물질의 안정성 개선이 미비하여 시약이 낭비되는 문제가 있다.In this case, the glycol dissolving agent may be used 1 to 30 parts by weight, preferably 5 to 20 parts by weight, most preferably 10 parts by weight based on 1 part by weight of the whitening improvement active substance. If the glycol-based solubilizer is contained in an amount of less than 1 part by weight based on 1 part by weight of the whitening-improving active substance, the dispersion of the whitening-improving active substance is incomplete, which makes it difficult to release the whitening-improving active substance in future use. If it exceeds 30 parts by weight with respect to 1 part by weight of the effective active material, there is a problem that the stability of the whitening improvement active material is insufficient and the reagent is wasted.
나아가, 상기 글리콜류 용해제에 의한 미백개선 유효물질의 용해도를 더욱 향상시키기 위하여 글리코푸롤, 폴리소르베이트, 크레모포어, 솔루톨 HS(Solutol HS 15) 등을 더 혼합하여 사용할 수 있다.Furthermore, in order to further improve the solubility of the whitening improvement active substance by the glycols solubilizer, glycofurol, polysorbate, cremophore, solutol HS (Solutol HS 15) and the like may be further mixed and used.
또한, 상기 [폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)] 형태의 트리블록 공중합체류는 마이셀 형성의 역할을 수행하며 폴록사머 184, 폴록사머 185, 폴록사머 188, 폴록사머 124, 폴록사머 237, 폴록사머 338, 폴록사머 407 등을 사용할 수 있다.In addition, the triblock copolymers in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)] play a role of micelle formation and have poloxamer 184, poloxamer 185, poloxamer 188, and polox. Sammer 124, Poloxamer 237, Poloxamer 338, Poloxamer 407 and the like can be used.
바람직하게 상기 트리블록 공중합체류는 하기 화학식 2로 표시되는 화합물이다.Preferably the triblock copolymers are compounds represented by the following formula (2).
[화학식 2][Formula 2]
상기 화학식 2에서,In Chemical Formula 2,
b, c 및 d는 독립적으로 1 내지 200의 정수이다.b, c and d are independently integers from 1 to 200.
여기서, 상기 트리블록 공중합체류는 미백개선 유효물질 1 중량부에 대하여 1 내지 30 중량부로 함유되는 것이 바람직하고, 5 내지 20 중량부로 함유되는 것이 더욱 바람직하고, 10 중량부로 함유되는 것이 가장 바람직하다. 만약, 상기 트리블록 공중합체류가 미백개선 유효물질 1 중량부에 대하여 1 중량부 미만으로 함유되는 경우에는 미백개선 유효물질의 침전이 발생하는 문제가 있고, 미백개선 유효물질 1 중량부에 대하여 30 중량부를 초과하는 경우에는 입자크기가 증가하여 안정성이 떨어지는 문제가 있다.Herein, the triblock copolymers are preferably contained in an amount of 1 to 30 parts by weight, more preferably 5 to 20 parts by weight, and most preferably 10 parts by weight, based on 1 part by weight of the whitening improvement active substance. If the triblock copolymers are contained in an amount of less than 1 part by weight based on 1 part by weight of the whitening improvement active substance, there is a problem that precipitation of the whitening improvement active substance occurs, and 30 parts by weight of 1 part by weight of the whitening improvement active substance. In the case of exceeding a part, there is a problem that the particle size is increased and stability is lowered.
나아가, 상기 피부투과촉진제는 디에틸렌글리콜 모노에틸에테르(Diethylene glycol monoethyl ether), 이소프로필미리스테이트(Isopropyl myristate), 이소스테아릴글리세릴에테르(Isostearyl glyceryl ether), 폴리소르베이트 80(polysorbate 80), 소르비탄 세스퀴올레이트(Sorbitan sesquioleate), 카프릴로카프로일 마크로골글리세라이드(Caprylocaproyl macrogolglycerides), 올레오일 마크로골글리세라이드(Oleoyl macrogolglycerides), 소듐라우릴설페이트(Sodium lauryl sulfate), 헥사데실트리메틸암모늄 브로마이드(Hexadecyltrimethylammonium bromide), 세트리미드(Cetrimide), 벤제토늄클로라이드(Benzethonium chloride), 세틸피리디늄클로라이드(Cetylpyridinium chloride), 폴리옥실-10-스테아릴에테르(Brij 56), 폴리옥실-20-세틸에테르(Brij 58), 폴리옥실-2-스테아릴에테르(Brij 72), 폴리옥실-10-스테아릴에테르(Brij 76), 폴리옥실-2-올레일에테르(Brij 93), 폴리옥실-10-올레일에테르(Brij 97), 폴리옥실-35-캐스터오일(Cremophor EL), 폴리옥실-40-하이드로제네이트(Cremophor RH40), 폴리옥실-60-하이드로제네이트(Cremophor RH60) 등을 사용할 수 있다. Furthermore, the skin permeation accelerator is diethylene glycol monoethyl ether, isopropyl myristate, isostearyl glyceryl ether, polysorbate 80, Sorbitan sesquioleate, Caprylocaproyl macrogolglycerides, Oleoyl macrogolglycerides, Sodium lauryl sulfate, Hexadecyltrimethyl ammonium bromide Hexadecyltrimethylammonium bromide, Cetrimide, Benzethonium chloride, Cetylpyridinium chloride, Polyoxyl-10-stearylether (Brij 56), Polyoxyl-20-cetylether (Brij 58), polyoxyl-2-stearyl ether (Brij 72), polyoxyl-10-stearyl ether (Brij 76), polyoxyl-2-olee Ether (Brij 93), polyoxyl-10-oleyl ether (Brij 97), polyoxyl-35-caster oil (Cremophor EL), polyoxyl-40-hydrogenate (Cremophor RH40), polyoxyl-60-hydro Zenate (Cremophor RH60) etc. can be used.
여기서, 상기 피부투과촉진제는 미백개선 유효물질 1 중량부에 대하여 0.5 내지 30 중량부로 함유되는 것이 바람직하다. 만약, 상기 피부투과촉진제가 미백개선 유효물질 1 중량부에 대하여 0.5 중량부 미만으로 함유되는 경우에는 피부투과가 우수한 효과를 확보하지 못하는 문제가 있고, 미백개선 유효물질 1 중량부에 대하여 30 중량부를 초과하는 경우에는 피부투과를 위해 요구되는 피부투과촉진제의 양보다 과량이 함유되어 시약이 낭비되는 문제가 있다.Here, the skin permeation promoter is preferably contained in 0.5 to 30 parts by weight based on 1 part by weight of the whitening improvement active substance. If the skin permeation accelerator is contained in an amount of less than 0.5 parts by weight based on 1 part by weight of the whitening improvement active substance, there is a problem that skin permeability is not secured, and 30 parts by weight based on 1 part by weight of the whitening improvement active substance. If it exceeds, there is a problem in that excess amount of the skin permeation accelerator required for skin permeation is contained and the reagent is wasted.
상기 미백개선 유효물질이 봉입된 나노입자는 미백개선 유효물질의 시간 경과에 따른 산화를 효과적으로 방지하여 미백개선 유효물질의 효능을 높이고 나노입자의 안정성을 확보하기 위하여 항산화제를 0.1 내지 1 중량부 더 포함할 수 있으며, α-리포산(α-lipoic acid), α-토코페롤(α-Tocopherol), 레티놀(Retinol), 글루타치온(Glutathione), 부틸화 히드록시 톨루엔(Butylated hydroxy toluene), 제니스테인(Genistein), 쿼세틴(Quercetin), 프로필 갈레이트(Propyl gallate), 에피갈로카테킨 갈레이트(Epigallocatechin gallate), 갈로카테킨 갈레이트(Gallocatechin gallate), 실리빈(Silybin), 디오스메틴(Diosmetin), 캠퍼롤(Kaempferol), 에피카테킨(Epicatechin), 갈란긴(Galangin) 등을 사용할 수 있다. The nanoparticles containing the whitening improvement active material effectively prevent oxidation over time of the whitening improvement active material to increase the efficacy of the whitening improvement active material and to increase the stability of the nanoparticles by 0.1 to 1 parts by weight. Α-lipoic acid, α-Tocopherol, α-Tocopherol, Retinol, Glutathione, Butylated hydroxy toluene, Genistein, Quercetin, Propyl gallate, Epigallocatechin gallate, Gallocatechin gallate, Silybin, Diosmetin, Kaempferol , Epicatechin, galangin, and the like can be used.
만약, 상기 항산화제가 미백개선 유효물질 1 중량부에 대하여 0.1 중량부 미만으로 함유되는 경우 미백개선 유효물질의 산화를 방지하지 못하는 문제가 있고, 미백개선 유효물질 1 중량부에 대하여 1 중량부를 초과하는 경우에는 미백개선 유효물질의 산화를 방지하기 위해 요구되는 산화방지제의 양보다 과량이 함유되어 시약이 낭비되는 문제가 있다.If the antioxidant is contained in an amount of less than 0.1 part by weight based on 1 part by weight of the whitening improvement active material, there is a problem that does not prevent the oxidation of the whitening improvement active material. In this case, there is a problem that the reagent is wasted because an excess amount of the antioxidant is required to prevent oxidation of the whitening improvement active substance.
[미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품 제조방법][Cosmetic Manufacturing Method Including Nanoparticles Encapsulated with Whitening Improvement Material]
또한, 본 발명은 미백개선 유효물질에 글리콜류용해제 및 [폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)] 형태의 트리블록 공중합체류를 첨가하여 교반하는 단계(단계 1); 및In addition, the present invention is a step of adding and stirring a glycol dissolving agent and a triblock copolymer in the form of [polyethylene oxide (PEO) -polypropylene oxide (PPO) -polyethylene oxide (PEO)] to the whitening improvement active material (step 1) ; And
피부투과촉진제를 첨가하여 분산시키는 단계(단계 2);를 포함하는 상기 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품 제조방법을 제공한다.It provides a cosmetic manufacturing method comprising the nanoparticles containing the whitening improvement active material comprising the step of adding and dispersing the skin permeation promoter (step 2).
본 발명에 따른 제조방법은, 미백개선 유효물질이 봉입된 20 내지 150 nm 입자크기를 갖는 나노입자를 포함하는 화장품을 제조할 수 있다. 이때, 상기 제조방법으로 제조되는 나노입자는, 상기 나노입자를 포함하는 화장품의 용해도를 향상시키고 장기 안정성이 우수하므로, 미백개선 유효물질을 미백개선 화장품으로서의 응용성을 향상시킬 수 있는 제조방법으로 유용하게 사용할 수 있다.The manufacturing method according to the present invention can produce a cosmetic including nanoparticles having a particle size of 20 to 150 nm in which the whitening improvement active material is encapsulated. At this time, the nanoparticles produced by the manufacturing method, improve the solubility of the cosmetic containing the nanoparticles and excellent long-term stability, it is useful as a manufacturing method that can improve the applicability of the whitening improvement active material as a whitening improvement cosmetics Can be used.
이하, 본 발명에 따른 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품 제조방법을 단계별로 상세히 설명한다.Hereinafter, a detailed description will be given step by step of a cosmetic manufacturing method comprising a nanoparticle encapsulated whitening improvement active material according to the present invention.
본 발명에 따른 미백개선 유효물질이 봉입된 나노입자의 제조방법에 있어서, 상기 단계 1은 미백개선 유효물질에 글리콜류용해제 및 [폴리에틸렌옥사이드(PEO)-폴리프로필렌옥사이드(PPO)-폴리에틸렌옥사이드(PEO)] 형태의 트리블록 공중합체류를 첨가하여 교반하는 단계이다.In the method for preparing a nanoparticle containing a whitening improving active material according to the present invention,
이때, 상기 교반온도는 20 내지 100℃일 수 있고, 40 내지 80℃가 바람직하다.At this time, the stirring temperature may be 20 to 100 ℃, 40 to 80 ℃ is preferred.
본 발명에 따른 미백개선 유효물질이 봉입된 나노입자의 제조방법에 있어서, 상기 단계 2는 피부투과촉진제를 첨가하여 분산시키는 단계이다.In the method for preparing nanoparticles containing the whitening improvement active material according to the present invention,
이때, 상기 단계 2를 수행하기 이전에 상기 단계 1을 수행한 후 항산화제를 첨가하는 단계를 더 수행할 수 있다.At this time, the step of performing the
이하, 본 발명을 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by Examples and Experimental Examples.
단, 하기 실시예 및 실험예는 본 발명의 예시하는 것일 뿐, 본 발명의 내용이 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following Examples and Experimental Examples are only illustrative of the present invention, and the content of the present invention is not limited by Examples and Experimental Examples.
<제조예 1> 글라브리딘(Glabridin)의 준비Preparation Example 1 Preparation of Glabridin
글라브딘은 인투바이오사에서 감초 유래 유용성 성분으로 개발한 것을 구입하여 준비하였다.Glavdine was prepared by purchasing a product developed by Intubio as a licorice-derived oil-soluble ingredient.
<제조예 2> 심 화이트(symwhite 377)의 준비<Manufacture example 2> Preparation of the seam white (symwhite 377)
심 화이트(symwhite 377, 페닐에틸 리소르시놀(Phenylethyl Resorcinol)는 독일의 Symrise사에서 구입하여 준비하였다.Sim white 377 (Phenylethyl Resorcinol) was prepared and purchased from Symrise, Germany.
<실시예 1> 액상 글라브리딘 나노입자를 포함하는 화장품의 제조Example 1 Preparation of Cosmetics Containing Liquid Glybridine Nanoparticles
글라브리딘 10mg에 폴리에틸렌글리콜(PEG400)(100mg)을 첨가한 후, 트리블록공중합체인 폴록사머 188(F-68, 100mg)을 넣고, 60℃에서 용융하여 액상 글라브리딘 나노입자를 포함하는 화장품을 제조하였다(도 2).After adding polyethylene glycol (PEG400) (100 mg) to 10 mg of glabridine, poloxamer 188 (F-68, 100 mg), which is a triblock copolymer, was added and melted at 60 ° C. to include cosmetic liquid granules containing nanoparticles. Was prepared (FIG. 2).
< 실시예 2> 피부투과에 용이한 액상 글라브리딘 나노입자를 포함하는 화장품의 제조 <Example 2> Preparation of cosmetic containing the easy liquid article L 'Abri Dean nanoparticles on skin penetration
상기 실시예 1 에서 제조된 액상 글라브리딘 나노입자에 피부투과촉진제(Brij 58) 100mg을 더 넣어 피부투과에 용이하도록 제조하였다(도 3).100 mg of the skin permeation accelerator (Brij 58) was further added to the liquid glabridine nanoparticles prepared in Example 1 to prepare for easy skin permeation (FIG. 3).
<실시예 3> 액상 심 화이트 나노입자를 포함하는 화장품의 제조Example 3 Preparation of Cosmetics Containing Liquid Shim White Nanoparticles
심 화이트 10mg에 폴리에틸렌글리콜(PEG400)(100mg)을 첨가한 후, 트리블록공중합체인 폴록사머 188(F-68, 100mg)을 넣고, 60℃에서 용융하여 액상 심 화이트 나노입자를 포함하는 화장품을 제조하였다(도 4).Polyethylene glycol (PEG400) (100 mg) was added to 10 mg of shim white, followed by addition of poloxamer 188 (F-68, 100 mg), a triblock copolymer, and melted at 60 ° C. to prepare a cosmetic containing liquid shim white nanoparticles. (FIG. 4).
< 실시예 4> 피부투과에 용이한 액상 심 화이트 나노입자를 포함하는 화장품의 제조 <Example 4> Preparation of cosmetic containing a liquid core easily isolated nanoparticles on skin penetration
상기 실시예 3 에서 제조된 액상 심 화이트 나노입자에 피부투과촉진제(Brij 58) 100mg을 더 넣어 피부투과에 용이하도록 제조하였다(도 5).100 mg of a skin permeation accelerator (Brij 58) was added to the liquid shim white nanoparticles prepared in Example 3, and thus prepared for easy skin permeation (FIG. 5).
< 실시예 5> 미백개선 성분의 산화 방지를 위한 미백개선 나노입자를 포함하는 화장품의 제조 <Example 5> Preparation of a cosmetics including nanoparticles whitening improvement for preventing oxidation of whitening improvement ingredient
심 화이트 10mg에 폴리에틸렌글리콜(PEG400)(100mg)과 항산화제인 α-토코페롤(5mg)을 첨가하고, 트리블록공중합체인 폴록사머 188(F-68, 100mg)을 첨가한 후 60℃에서 용융하여 액상 나노입자를 제조하였고, 제조한 미백개선 나노입자 조성물에 피부투과촉진제(Brij 58) 100mg을 넣어 산화반응에도 안정하고 피부투과가 촉진된 미백개선 나노입자를 포함하는 화장품을 제조하였다.Polyethylene glycol (PEG400) (100 mg) and α-tocopherol (5 mg), antioxidants, were added to Shim White, and poloxamer 188 (F-68, 100 mg), a triblock copolymer, was melted at 60 ° C and then dissolved in liquid nano. Particles were prepared, and 100 mg of skin permeation accelerator (Brij 58) was added to the prepared whitening nanoparticle composition to prepare a cosmetic including whitening nanoparticles that are stable to oxidation reaction and promote skin permeation.
<실험예 1> 장기 안정성 평가Experimental Example 1 Long-term Stability Evaluation
본 발명에 따른 미백개선 나노입자를 포함하는 화장품의 장기 안정성을 평가하기 위해, 다음과 같은 실험을 하였다.In order to evaluate the long-term stability of the cosmetic containing the whitening improvement nanoparticles according to the present invention, the following experiment was performed.
상기 제조된 실시예 1 내지 5의 미백개선 나노입자를 제조 후 시간 경과에 따라 육안으로 침전 여부를 관찰하여 그 결과를 표 1에 나타내었고, 시간 경과에 따른 변색 여부를 관찰하기 위해 1개월 후 육안 관찰하여 그 결과를 도 6 및 도 7에 나타내었으며, 실시예 2의 글라브리딘의 시간 경과에 따른 입자크기를 측정하여 도 8에 나타냈다.The whitening improvement nanoparticles of Examples 1 to 5 prepared above were observed with the naked eye over time after preparation, and the results are shown in Table 1, and the result was visually observed after one month to observe the discoloration over time. 6 and 7 show the results, and the particle size of the gloridine of Example 2 over time was measured and shown in FIG. 8.
표 1은 실시예 1 내지 실시예 5의 침전 여부를 나타낸 표이다.Table 1 is a table showing the precipitation of Examples 1 to 5.
도 6은 1개월 후, 실시예 4의 변색 된 미백개선 나노입자의 사진이다.6 is a photograph of the discolored whitening improvement nanoparticles of Example 4 after one month.
도 7은 1개월 후, 실시예 5의 변색 된 미백개선 나노입자의 사진이다.7 is a photograph of the discolored whitening improvement nanoparticles of Example 5 after one month.
도 8은 본 발명에 따른 글라브리딘의 입자크기를 시간 경과에 따라 나타낸 그래프이다.8 is a graph showing the particle size of the glabridine over time according to the present invention.
도 6과 도 7을 살펴보면, 실시예 4는 1개월 후 미백개선 화합물이 산화되어 변색이 일어났으나, 실시예 5는 1개월 후에도 변색이 일어나지 않아 산화반응에 안정한 미백개선 나노입자임을 알 수 있다.Referring to FIGS. 6 and 7, in Example 4, after one month, the whitening improvement compound was oxidized and discolored. However, in Example 5, discoloration does not occur even after one month, and thus whitening improvement nanoparticles are stable to the oxidation reaction. .
도 8을 살펴보면, 본 발명에 따른 미백개선 나노입자의 글라브리딘은 6개월 경과 후에도 그 입자 크기를 유지하는 것으로 보아 장기 안정성이 우수하다는 것을 알 수 있다.Referring to Figure 8, the glabridine of the whitening improved nanoparticles according to the present invention can be seen that the long-term stability is excellent as it maintains the particle size even after 6 months.
따라서, 본 발명에 따른 미백개선 나노입자는 피부투과 촉진제를 포함하여 가용성이 우수하고, 항산화제를 더 포함함으로써 미백개선 물질의 산화를 막아 장기 안정성을 향상시킬 수 있고, 장시간 경과 후에도 그 입자크기를 유지할 수 있어, 이를 유효성분으로 함유하여 미백개선용 화장품으로 유용하게 사용될 수 있다.Therefore, the whitening improvement nanoparticles according to the present invention have excellent solubility including skin permeation accelerator, and further include an antioxidant to prevent oxidation of the whitening improvement substance, thereby improving long-term stability, and its particle size even after a long time Since it can be maintained, it can be usefully used as a cosmetic for improving whitening by containing it as an active ingredient.
<실험예 2> 미백개선 나노입자 크기 측정Experimental Example 2 Measurement of Whitening Improvement Nanoparticle Size
본 발명에 따른 미백개선 나노입자를 포함하는 화장품이 피부투과에 적합한 크기를 갖는지 평가하기 위해 상기 실시예 1 내지 5의 입자크기를 측정하였다.The particle size of Examples 1 to 5 was measured to evaluate whether the cosmetic including the whitening-improving nanoparticles according to the present invention has a size suitable for skin permeation.
미백개선 나노입자의 측정된 결과를 표 2, 도 9, 도 10, 도 11, 도 12 및 도 13에 나타내었다.The measured results of the whitening improvement nanoparticles are shown in Table 2, 9, 10, 11, 12 and 13.
표 2를 살펴보면, 피부투과 촉진제를 첨가한 실시예 2, 4 및 5의 미백개선 나노입자가 피부투과 촉진제가 포함되지 않은 실시예 1과 실시예 3의 미백개선 나노입자보다 입자크기가 작은 것을 확인할 수 있다.Looking at Table 2, it was confirmed that the whitening-improving nanoparticles of Examples 2, 4 and 5 to which the skin permeation accelerator was added are smaller in particle size than the whitening-improving nanoparticles of Examples 1 and 3 that do not contain the skin permeation promoter. Can be.
따라서, 피부투과 촉진제를 포함함으로써 본 발명의 미백개선 나노입자를 포함하는 화장품은 용이하게 피부를 투과할 수 있는 효과를 얻을 수 있다.Therefore, by including a skin permeation accelerator, a cosmetic including the whitening-improving nanoparticles of the present invention can easily obtain the effect of permeating the skin.
<실험예 3> 미백효과 평가Experimental Example 3 Evaluation of Whitening Effect
본 발명의 미백개선 화합물의 미백효과를 평가하기 위해, 다음과 같은 실험을 하였다.In order to evaluate the whitening effect of the whitening improvement compound of the present invention, the following experiment was carried out.
티로시나제(Tyrosinase) 작용 결과 생성되는 도파크롬(DOPA chrome)을 비색법에 의해 측정하는 방법을 변형하여, 본 발명의 실시예에서 사용된 글라브리딘 또는 다른 종류의 미백기능성 화합물인 심 화이트의 티로시나제활성 억제력을 측정하였다.Modification of the method of measuring dopa chrome produced by the action of tyrosinase by colorimetric method, inhibiting tyrosinase activity of shim white, which is a glabridine or another kind of whitening functional compound used in the embodiment of the present invention Was measured.
구체적으로, 0.1M 인산 완충액(Phosphate buffer, pH 6.5) 110μl의 96-웰 플레이트(well plate)에 1.5mM L-타이로신(L-Tyrosine) 용액 40μl과 글라브리딘 또는 심 화이트를 각각 10μl씩 넣은 후, 버섯형 티로시나제(mushroom tyrosinase, 2000 unit/ml) 10μl을 첨가하여 37℃에서 10분간 반응시켜 반응액 중에 생성된 도파크롬을 마이크로플레이트 계수기를 이용하여 490nm에서 측정하였으며 실험결과의 비교를 위해 양성대조 물질로 알부틴(Arbutin)을 사용하였고, 실험결과를 표 3에 나타내었다.Specifically, 40 μl of 1.5mM L-Tyrosine solution and 10 μl of glabridine or shim white were added to a 96-well plate of 110 μl of 0.1 M Phosphate buffer (pH 6.5). 10 μl of mushroom tyrosinase (2000 unit / ml) was added and reacted at 37 ° C. for 10 minutes to measure dopachrome at 490 nm using a microplate counter. Arbutin was used as the substance, and the experimental results are shown in Table 3.
표 3을 살펴보면, 알부틴은 상대적으로 높은 농도의 용액으로 실험을 했음에도 티로시나제 억제효과가 50 내지 70% 정도로 나타나는 반면, 상대적으로 낮은 농도의 용액임에도 피부투과에 용이한 글라브리딘과 심 화이트 나노입자는 80%이상의 효과로 티로시나제를 억제한 것으로 나타나 우수하게 멜라닌형성을 억제하는 것을 알 수 있다.Table 3 shows that arbutin exhibits a tyrosinase inhibitory effect of 50 to 70% even when tested with a relatively high concentration of solution, whereas glabridine and seam white nanoparticles, which are easy to penetrate the skin even with a relatively low concentration of solution, It was found that the tyrosinase was suppressed by an effect of 80% or more, which shows that the melanogenesis was excellently suppressed.
따라서, 본 발명의 미백개선 유효물질은 멜라닌형성을 억제하여 미백개선이 우수하고, 이를 유효성분으로 함유하는 본 발명의 미백개선 나노입자를 포함하는 화장품은 미백개선의 효과를 얻을 수 있다.Therefore, the whitening improvement active substance of the present invention is excellent in whitening improvement by inhibiting melanin formation, and cosmetics containing the whitening improvement nanoparticles of the present invention containing the same as an active ingredient can obtain the effect of whitening improvement.
상기 실험예 1 내지 실험예 3을 통해 알 수 있듯이, 본 발명에 따른 미백개선 나노입자를 포함하는 화장품은 입자크기가 작아(20 내지 150nm) 가용성과 피부투과가 우수하고, 효과적으로 미백개선 화합물의 산화를 막아 장기 안정성이 뛰어나기 때문에, 이를 유효성분으로 함유하여 미백개선 화장품으로 유용하게 사용될 수 있다.As can be seen through Experimental Example 1 to Experimental Example 3, the cosmetics containing the whitening improvement nanoparticles according to the present invention has a small particle size (20 to 150nm) is excellent in solubility and skin permeability, effectively oxidizing the whitening improvement compound Because it prevents the long-term stability is excellent, it can be usefully used as a whitening improvement cosmetics containing it as an active ingredient.
아울러 상기 구성의 미백개선 유효물질이 봉입된 나노입자를 포함하는 화장품은 공지의 기술에 의한 화장품 조성물에 혼합되는 구성을 할 수 있고, 각각의 조성비는 당업자의 판단에 따라 적절하게 구성 가능하다.In addition, the cosmetic containing the nanoparticles containing the whitening improvement active material of the above configuration can be configured to be mixed in the cosmetic composition according to a known technique, each composition ratio can be appropriately configured according to the judgment of those skilled in the art.
또한 본 발명에 의한 화장품은 스킨, 토너, 에센스, 에멀젼, 로션, 크림, 페이스 미스트, 클렌징 또는 페이스 팩의 에멀젼 등과 같은 종류의 것으로 구분될 수 있는 화장품의 유효성분으로서 사용될 수 있다. 즉, 상기 종류의 화장품은 제형에 따라 구분되어 본 발명에 의한 화장품을 유효성분으로 하고 각각의 제형을 이루기 위한 다양한 종류의 담체 성분을 더 포함하는 구성을 할 수 있다.In addition, the cosmetics according to the present invention can be used as an active ingredient of cosmetics that can be classified into a kind such as skin, toner, essence, emulsion, lotion, cream, face mist, cleansing or face pack emulsion. That is, the kind of cosmetics can be divided according to the dosage form as an active ingredient according to the present invention and may further comprise a variety of carrier components for forming each formulation.
바람직하게는, 본 발명에 의한 화장품을 유효성분으로 하고, 제조되는 화장품의 제형이 페이스트, 크림 또는 겔인 경우에는, 상기 담체 성분은 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 중 어느 하나 이상의 것이 이용될 수 있다.Preferably, when the cosmetic according to the present invention is an active ingredient, and the formulation of the cosmetic to be prepared is a paste, cream or gel, the carrier component is animal fiber, plant fiber, wax, paraffin, starch, trakant, cellulose derivative. , Polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used.
또한 본 발명에 의한 화장품을 유효성분으로 하고, 제조되는 화장품의 제형이 파우더 또는 스프레이인 경우에는, 상기 담체 성분은 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더 중 어느 하나 이상의 것이 이용될 수 있고, 특히 제형이 스프레이인 경우에는 추가적으로 클로로 플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르 중 어느 하나 이상의 추진체를 더 포함할 수 있다.In addition, when the cosmetic according to the present invention as an active ingredient, and the formulation of the cosmetic to be prepared is a powder or a spray, the carrier component is any one or more of lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder May be used, and in particular when the formulation is a spray, it may further comprise a propellant of any one or more of chloro fluorohydrocarbon, propane / butane or dimethyl ether.
아울러 본 발명에 의한 화장품을 유효성분으로 하고, 제조되는 화장품의 제형이 용액 또는 유탁액의 경우에는, 상기 담체 성분은 용매, 용매화제 또는 유탁화제가 이용될 수 있다. 보다 상세하면 상기 담체 성분은 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 중 어느 하나 이상의 것이 될 수 있다.In addition, the cosmetic according to the present invention as an active ingredient, in the case of the formulation of the cosmetic to be prepared is a solution or emulsion, the carrier component may be used as a solvent, solvating agent or emulsifying agent. More specifically, the carrier component may be selected from fatty acid esters of water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan. It can be any one or more.
더불어 본 발명에 의한 화장품을 유효성분으로 하고, 제조되는 화장품의 제형이 현탁액인 경우에는, 상기 담체 성분은 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타 히드록시드, 벤토나이트, 아가 또는 트라칸트 중 어느 하나 이상의 것이 이용될 수 있다.In addition, when the cosmetic preparation according to the invention as an active ingredient, and the formulation of the cosmetic preparation is a suspension, the carrier component is a liquid diluent such as water, ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester And suspending agents such as polyoxyethylene sorbitan esters, microcrystalline cellulose, aluminum meta hydroxide, bentonite, agar or tracant.
또한 본 발명에 의한 화장품을 유효성분으로 하고, 제조되는 화장품의 제형이 계면-활성제 함유 클린징인 경우에는, 상기 담체 성분은 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린유도체 또는 에톡실화 글리세롤 지방산 에스테르 중 어느 하나 이상의 것이 이용될 수 있다.In addition, when the cosmetic according to the present invention as an active ingredient, and the formulation of the cosmetic is prepared with a surfactant-containing cleansing, the carrier component is aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, already Dazolinium derivatives, methyltaurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters The above can be used.
상기와 연관하여, 상기 종류의 담체는 제조되는 화장품의 용도에 따라 본 발명에 의한 화장품(제조되는 화장품의 유효성분으로서의 역할을 함.)과 다양한 조성비로 혼합될 수 있고, 그에 대한 바람직한 조성비는 공지의 기술을 적절하게 적용할 수 있다.In connection with the above, the carrier of this kind may be mixed with cosmetics according to the present invention (which serves as an active ingredient of the cosmetics to be manufactured) in various composition ratios, and the preferred composition ratios thereof are known according to the use of the cosmetics produced. The technique can be applied as appropriate.
상기는 본 발명의 바람직한 실시예를 참고로 설명하였으며, 상기의 실시예에 한정되지 아니하고, 상기의 실시예를 통해 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 본 발명의 요지를 벗어나지 않는 범위에서 다양한 변경으로 실시할 수 있는 것이다.The above has been described with reference to a preferred embodiment of the present invention, but is not limited to the above embodiment, the person having ordinary skill in the art to which the present invention pertains through the above embodiments without departing from the gist of the present invention Can be implemented in a variety of changes.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201680034087.1A CN108401417A (en) | 2016-12-05 | 2016-12-05 | Including improving the cosmetics of nano-particle and preparation method thereof of active principle containing whitening |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160164046 | 2016-12-05 | ||
| KR10-2016-0164046 | 2016-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2018105755A1 true WO2018105755A1 (en) | 2018-06-14 |
Family
ID=62491028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2016/014163 Ceased WO2018105755A1 (en) | 2016-12-05 | 2016-12-05 | Cosmetics containing nanoparticles having encapsulated therein whitening-improving active ingredient, and method for producing said cosmetics |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN108401417A (en) |
| WO (1) | WO2018105755A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114796008A (en) * | 2022-05-31 | 2022-07-29 | 深圳市萱嘉生物科技有限公司 | Preparation method and application of supramolecular composition with whitening and moisturizing effects |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110200928A (en) * | 2019-07-23 | 2019-09-06 | 成秋宸 | Genistein nano freeze-dried powder is inhibiting the application in cicatrix of skin formation and fibrosis of skin |
| US11554087B2 (en) | 2020-11-05 | 2023-01-17 | The Gillette Company Llc | Shaving aid comprising an antioxidant |
| CN114306196B (en) * | 2021-12-31 | 2024-01-23 | 深圳市瑞茵电子科技有限公司 | Preparation method of self-assembled whitening active compound micelle and skin care product |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010018272A (en) * | 1999-08-18 | 2001-03-05 | 김명섭 | Hydrophilic and external gel formulations containing kojic acid for the treatment of discoloration and freckle |
| KR20020060054A (en) * | 2000-12-21 | 2002-07-16 | 차알스 제이. 메츠 | Personal care compositions |
| KR20100125278A (en) * | 2008-02-01 | 2010-11-30 | 암콜 인터내셔널 코포레이션 | Improved skin brightening compositions |
| KR20120022368A (en) * | 2010-09-02 | 2012-03-12 | 대화제약 주식회사 | A transdermal composition of escitalopram |
| CN103385806B (en) * | 2013-08-08 | 2015-08-12 | 珀莱雅化妆品股份有限公司 | A kind of method suppressing skin-lightening cosmetic to turn yellow |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017529334A (en) * | 2014-08-27 | 2017-10-05 | アッヴィ・インコーポレイテッド | Topical formulation |
-
2016
- 2016-12-05 WO PCT/KR2016/014163 patent/WO2018105755A1/en not_active Ceased
- 2016-12-05 CN CN201680034087.1A patent/CN108401417A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010018272A (en) * | 1999-08-18 | 2001-03-05 | 김명섭 | Hydrophilic and external gel formulations containing kojic acid for the treatment of discoloration and freckle |
| KR20020060054A (en) * | 2000-12-21 | 2002-07-16 | 차알스 제이. 메츠 | Personal care compositions |
| KR20100125278A (en) * | 2008-02-01 | 2010-11-30 | 암콜 인터내셔널 코포레이션 | Improved skin brightening compositions |
| KR20120022368A (en) * | 2010-09-02 | 2012-03-12 | 대화제약 주식회사 | A transdermal composition of escitalopram |
| CN103385806B (en) * | 2013-08-08 | 2015-08-12 | 珀莱雅化妆品股份有限公司 | A kind of method suppressing skin-lightening cosmetic to turn yellow |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114796008A (en) * | 2022-05-31 | 2022-07-29 | 深圳市萱嘉生物科技有限公司 | Preparation method and application of supramolecular composition with whitening and moisturizing effects |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108401417A (en) | 2018-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2018105755A1 (en) | Cosmetics containing nanoparticles having encapsulated therein whitening-improving active ingredient, and method for producing said cosmetics | |
| WO2016159519A1 (en) | Cosmetic composition with multiple emulsion formulation having lamellar liquid crystal structure | |
| WO2020105840A1 (en) | Composition for stabilizing poorly soluble components and cosmetic composition comprising same | |
| WO2024075908A1 (en) | Cosmetic composition for enhancing skin absorption and formulation stability | |
| WO2019088455A1 (en) | Fine dust-proof composition | |
| WO2012173458A9 (en) | Stabilized active materials contained in plant cells and method for preparing same | |
| WO2002067900A1 (en) | Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same | |
| WO2018124572A1 (en) | Silicon resin composition, preparation method therefor, and scar treatment agent including same | |
| WO2017003129A1 (en) | Makeup cosmetic composition comprising lamella structure | |
| WO2019059512A9 (en) | Cosmetic composition containing purpurogallin for skin protection against reactive oxygen species, ultraviolet radiation, or fine dust | |
| WO2015072602A1 (en) | Solution solubilization composition of insoluble material and method for solubilizing insoluble material using same | |
| WO2019132070A1 (en) | Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics | |
| WO2025164995A1 (en) | Dual-functional cosmetic composition having excellent potency retention and formulation stability of vitamin c and improved fragrance | |
| WO2019027221A2 (en) | Composition for stabilizing ph-sensitive component | |
| WO2017018634A1 (en) | Pharmaceutical composition for oral administration comprising high concentration taxane | |
| WO2024195911A1 (en) | Phased hair color composition and cosmetic composition comprising same | |
| WO2023085677A1 (en) | Capsule composition for cosmetics and cosmetic composition comprising same | |
| WO2019151800A1 (en) | Cosmetic composition for generating hydrogen and method for generating hydrogen by using same | |
| WO2024225601A1 (en) | Graded hair color composition and cosmetic composition comprising same | |
| WO2022131654A1 (en) | Water-soluble emulsion composition containing ecdysteroid | |
| WO2023182857A1 (en) | Cosmetic composition with improved skin absorption | |
| WO2017003092A1 (en) | Cosmetic composition having high dosage form stability | |
| WO2022131653A1 (en) | Water-soluble emulsion composition containing natural polyphenol compound | |
| WO2017131403A1 (en) | Composition for preventing hair loss, promoting hair growth or promoting hair regrowth, and preparation method therefor | |
| WO2009082185A1 (en) | Skin-whitening agent containing platycodin d |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16923487 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16923487 Country of ref document: EP Kind code of ref document: A1 |